# Myosotis

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/myosotis

- Industry: Software
- Headquarters: Berlin, Germany
- Website: www.myo.de
- Total disclosed funding: $13M
- Latest round: Series A (Dec 19, 2023)
- Investors on record: 9

## About

Based in Germany, Myosotis GmbH provides a digital communication platform tailored for the eldercare sector, enhancing interactions among care facilities, families, and service providers through its app.Founded in 2017, Myosotis GmbH specializes in developing digital solutions for the eldercare industry. The company has not undergone any significant changes in its business strategy and does not operate as a subsidiary. Myosotis GmbH was established in Berlin, Germany, with Katerina Bush as one of the founders. The company has successfully raised EUR 10.5 million in its latest funding round, the Series A, led by TVM Capital Life Science, with a total amount raised of EUR 10.5 million and a current valuation of EUR 30.94 million.Myo is a digital communication platform designed specifically for the eldercare sector, facilitating seamless interaction among care facilities, families, and service providers. The core offering of Myo is its user-friendly app, which enhances operational efficiency by connecting caregiving staff with residents' families and external service vendors. Key functionalities include menu planning, food ordering, and sharing resident preferences through its kitchen module, while also enabling family communication via photos, videos, documents, and video calls. The platform is tailored to improve workflows in nursing homes, ensuring that staff, residents, and families benefit from transparent and secure communication channels. Myo serves a diverse customer base, primarily comprising nursing homes and eldercare facilities across Germany, offering its services to enhance the quality of care provided to the elderly.Myo generates revenue primarily through the integration costs associated with its digital platform, which are typically borne by the care facilities that adopt the service. The business model is focused on a B2B structure, wherein nursing homes and eldercare facilities pay for the implementation and use of the Myo app. This financial arrangement allows facilities the discretion to pass on costs to families if they choose. Transactions may include one-time integration fees as well as ongoing support services, providing assistance with both on-site and online training for facility staff.In December 2023, Myosotis GmbH raised EUR 10.5 million in Series A funding led by TVM Capital Life Science, with participation from TWIP Impact Ventures, Capacura, Baby Royal RE GmbH, Mountain Partners, and BonVenture. The company plans to utilize this funding to support its expansion into the UK and DACH regions. The investment is aimed at facilitating the development of new products and enhancing its market presence within these geographic areas.

## Funding rounds

- Series A, Dec 19, 2023, $11M — TVM Capital Life Science, Mountain Partners, BONVENTURE, capacura, Baby Royal RE, TWIP Impact Ventures
- Seed, Dec 17, 2018, $1.7M — Mountain Partners, Axel Springer Plug and Play Accelerator, Think.Health Ventures, AGAPLESION gAG

## Investors

- Mountain Partners (https://capitalatlas.ai/funds/mountain-partners) — Seed, Series A
- Axel Springer Plug and Play Accelerator — Seed
- Think.Health Ventures (https://capitalatlas.ai/funds/think-health-ventures) — Seed
- AGAPLESION gAG — Seed
- TVM Capital Life Science (https://capitalatlas.ai/funds/tvm-capital-life-science) — Series A
- BONVENTURE (https://capitalatlas.ai/funds/bonventure) — Series A
- capacura (https://capitalatlas.ai/funds/capacura) — Series A
- Baby Royal RE — Series A
- TWIP Impact Ventures — Series A